Overview
Man's best friend is also big business for CVS Group. The group, through subsidiary CVS (UK) Limited, has grown by attracting a four-legged following and, more so, through acquisition of veterinary practices that broaden its range of services. It operates more than 220 clinics and a half-dozen diagnostic laboratories across the UK, as well a pet crematorium and an online dispensary of medicines and pet products. Vet services focus on small pets
...
Read More and include annual vaccinations, dental work, emergency care, home visits, hospitalization, surgery, and weight management. Some of its practices are clustered in close proximity to enable internal referrals among the group's surgeons and specialists, and pet cemetery.
Read Less
Read More and include annual vaccinations, dental work, emergency care, home visits, hospitalization, surgery, and weight management. Some of its practices are clustered in close proximity to enable internal referrals among the group's surgeons and specialists, and pet cemetery.
Read Less
Joanne Mary Shaw
See more contacts
Other Professional, Scientific, and Technical Services
,
Professional, Scientific, and Technical Services
,
Veterinary services, specialties
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Scientific Research and Development Services
,
Specialized Design Services
?
$823.16 million
Actual
9.92%
-85.2%
$690
JUN
?
?
London SETS:CVSG
Contacts
Get in Touch with 8 Principals* and 230 Contacts
-
Joanne Mary ShawDirector
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of June 30, 2024 (12 month period) in USD
Annual Revenue 2024
$823.16 million
USD
Actual
1 USD = 0.7864 GBP
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $86 | $107 | $96 |
| Net Investing Cash | -$179 | -$127 | -$57 |
| Net Financing Cash | $87 | -$15 | -$19 |
| Net Change in Cash | -$6 | -$35 | $19 |
| Cash at Beginning of Period | $27 | $62 | $43 |
| Cash at End of Period | $21 | $27 | $62 |
| Capital Expenditure | -$55 | -$58 | -$31 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $21 | $27 | $62 |
| Accounts Receivable | $38 | $37 | $35 |
| Inventories | $40 | $36 | $33 |
| Other Current Assets | $64 | $42 | $32 |
| Asset Summary | |||
| Total Current Assets | $164 | $142 | $163 |
| Tangible Fixed Assets | $287 | $260 | $218 |
| Intangible Assets | $144 | $119 | $122 |
| Total Assets | $690 | $572 | $518 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $64 | $53 | $51 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $86 | $81 | $78 |
| Liability Summary | |||
| Total Current Liabilities | $150 | $134 | $129 |
| Long-Term Debt | $231 | $117 | $107 |
| Other Long-Term Liabilities | $ | -$1 | $ |
| Total Liabilities | $546 | $401 | $383 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | $269 | $266 | $218 |
| Equity Summary | |||
| Total Equity | $331 | $327 | $276 |
| Shares Outstanding | 71,731,969 | 71,423,518 | 71,120,037 |